ADAR1 promotes tumor growth by suppressing dsRNA sensing. (Left) Increased ADAR1 expression in tumors (red arrow) leads to efficient editing of endogenous dsRNAs, including abnormal dsRNAs that may accumulate in cancer cells. Through editing dependent and independent mechanisms, ADAR1 inhibits spontaneous activation of MDA5 and PKR, thus promoting tumor growth and preventing immune recognition, even in the presence of checkpoint inhibitors. (Right) ADAR1 deletion unleashes the innate immune response against cellular dsRNAs in cancer cells, leading to inflammation and enhanced sensitivity to checkpoint inhibitors (via the MDA5 pathway) and triggering apoptosis (via the PKR pathway).